Dennis J. Carlo Ph.D. files SEC Form 4 disclosures for Adamis Pharmaceuticals Corp. They have made 2 open-market trades across 1 company since 2019, most recently 2022-05-25.
CIK 0001038322
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ADMP | 535,867 | $415K |
Shares reported on the most recent Form 4, priced at the 2022-05-27 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ADMP | SELL · 10b5-1 | 2022-03-18 | 2022-03-22 | $0.60 | $6K | -10.4% | -29.7% | -36.0% |
| ADMP | SELL | 2021-12-01 | 2021-12-03 | $0.79 | $38K | -4.2% | -8.5% | -1.8% |
| ADMP | SELL · 10b5-1 | 2020-11-18 | 2020-11-20 | $0.41 | $4K | +14.5% | +20.4% | +227.7% |
| ADMP | SELL · 10b5-1 | 2020-08-18 | 2020-08-20 | $0.87 | $10K | -29.7% | -12.7% | -55.0% |
| ADMP | SELL · 10b5-1 | 2020-05-18 | 2020-05-20 | $0.56 | $6K | +7.4% | +29.2% | +112.2% |
| ADMP | SELL · 10b5-1 | 2020-03-18 | 2020-03-19 | $0.34 | $4K | +6.3% | +1.2% | +92.4% |
| ADMP | SELL · 10b5-1 | 2020-02-24 | 2020-02-26 | $0.60 | $7K | -6.2% | -27.0% | +0.4% |
| ADMP | SELL · 10b5-1 | 2019-11-18 | 2019-11-20 | $0.84 | $9K | -45.7% | -44.4% | -27.6% |
| ADMP | SELL · 10b5-1 | 2019-08-19 | 2019-08-21 | $1.06 | $11K | -20.8% | -30.2% | -10.0% |
| ADMP | SELL · 10b5-1 | 2019-05-20 | 2019-05-22 | $1.73 | $19K | -9.3% | -21.0% | -34.0% |
| ADMP | SELL | 2019-03-20 | 2019-03-22 | $2.27 | $30K | -2.4% | -8.1% | -37.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.